PRESS RELEASE
News
-
-
PRESS RELEASE
Original-Research: Marinomed Biotech AG (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research initiates coverage on Marinomed Biotech AG with a Buy rating and EUR 50.00 price target. Details of the company's dual business model and lead candidate, Budesolv, are highlighted -
-
PRESS RELEASE
EQS-Adhoc: The Payments Group Holding GmbH & Co. KGaA: The Payments Group Holding wins important victory against SGT Beteiligungsberatung GmbH in court
The Payments Group Holding wins court case against SGT Beteiligungsberatung GmbH, affirming financial claims. PGH pursues further claims in court. Landmark legal victory in Frankfurt am Main -
PRESS RELEASE
Acceptance period starts: shareholders can now tender their shares in the voluntary public tender offer for H&R GmbH & Co. KGaA
Acceptance period starts for H&R Holding GmbH's voluntary public tender offer for H&R GmbH & Co. KGaA. Shareholders can now tender their shares at EUR 5.00 per share until 11 August 2025 -
PRESS RELEASE
EQS-Adhoc: voestalpine AG: voestalpine AG passes resolution of new capital allocation- and dividend policy
voestalpine AG passes resolution of new capital allocation and dividend policy to support the 2030+ corporate strategy by providing clear guidelines for investment decisions and managing the balance sheet structure -
PRESS RELEASE
EQS-Adhoc: MAHLE has successfully priced new unsecured EUR 300 million bond and is launching a partial tender offer for its outstanding unsecured EUR 750 million bond
MAHLE GmbH successfully prices EUR 300 million bond and launches tender offer for EUR 750 million bond. Details on new notes and financial outlook provided -
-
-
PRESS RELEASE
hep global GmbH: Challenging environment led to shifts in revenue and earnings in 2024 – growth expected again in 2025
hep global GmbH experienced a challenging fiscal year in 2024 with shifts in revenue and earnings, but predicts growth in 2025. Strategic measures implemented to counter challenging market conditions
